Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: F. Jay Abella, III who wrote (568)	5/7/1998 4:40:00 PM
From: Paul S.	Read Replies (1) \| Respond to of 1185

FJA, I spoke with IR today about the news, there has been an up front payment made to NRT but due to a confidentiality agreement with LeRoche they are unable to disclose the amount.

To: F. Jay Abella, III who wrote (568)	5/7/1998 8:13:00 PM
From: SOROS	Respond to of 1185

Just flew in from looking at a gold mine -- returned to a platinum find. 86.5 million ROYALTY on 2.5 million people and 160,000 new cases each year 100 countries 70,000 employees 12 billion U.S. income You gotta ask yourself 4 questions: 1. How many companies has Hoffmann-La Roche announced this size deal with? scratch head . . . thinking . . . ummmmmmmmm! 2. How many drugs does Nortran have? One? More. Two? More. Three? More. Four? uh, you get the picture. 3. How big is Hoffmann-La Roche anyway, and do they really know what they are doing? Thinking again . . . ahhhhhhhhh! and 4. What color Rolls Beetle do you like best? I remain, SOROS ps somebody slap this goofy grin off my face